298 related articles for article (PubMed ID: 33313998)
1. Practical Recommendations for the Topical Treatment of Atopic Dermatitis in South and East Asia.
Luk D; Hon KLE; Dizon MVC; Leong KF; Tay YK; Koh MJ; Chandran NS; Wananukul S; Chatproedprai S; Luger T
Dermatol Ther (Heidelb); 2021 Feb; 11(1):275-291. PubMed ID: 33313998
[TBL] [Abstract][Full Text] [Related]
2. A practical algorithm for topical treatment of atopic dermatitis in the Middle East emphasizing the importance of sensitive skin areas.
Reda AM; Elgendi A; Ebraheem AI; Aldraibi MS; Qari MS; Abdulghani MMR; Luger T
J Dermatolog Treat; 2019 Jun; 30(4):366-373. PubMed ID: 30222017
[No Abstract] [Full Text] [Related]
3. Paediatric atopic eczema (atopic dermatitis) in South Africa: A practical algorithm for the management of mild-to-moderate disease in daily clinical practice.
Kannenberg SM; Karabus S; Visser WI; Aboobaker J; Kriel MM; Levin M; Magigaba B; Manjra A; Misra R; Mpofu P; Tshigabe A; Luger T
S Afr Fam Pract (2004); 2020 Nov; 62(1):e1-e9. PubMed ID: 33314940
[TBL] [Abstract][Full Text] [Related]
4. Experts' Consensus on the Use of Pimecrolimus in Atopic Dermatitis in China: A TCS-Sparing Practical Approach.
Zhao Z; Gao XH; Li W; Wang H; Liang Y; Tang J; Yao X; Zhao H; Luger T
Dermatol Ther (Heidelb); 2022 Apr; 12(4):933-947. PubMed ID: 35313362
[TBL] [Abstract][Full Text] [Related]
5. Practical algorithm to inform clinical decision-making in the topical treatment of atopic dermatitis.
Luger T; Adaskevich U; Anfilova M; Dou X; Murashkin NN; Namazova-Baranova L; Nitochko O; Reda A; Svyatenko TV; Tamay Z; Tawara M; Vishneva EA; Vozianova S; Wang H; Zhao Z
J Dermatol; 2021 Aug; 48(8):1139-1148. PubMed ID: 33963603
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for pimecrolimus 1% cream in the treatment of mild-to-moderate atopic dermatitis: from medical needs to a new treatment algorithm.
Luger T; De Raeve L; Gelmetti C; Kakourou T; Katsarou A; Lambert J; Morren MA; Oranje A; Ruer M; Serdaroglu S; Torrelo A; Werfel T
Eur J Dermatol; 2013; 23(6):758-66. PubMed ID: 24185493
[TBL] [Abstract][Full Text] [Related]
8. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
9. Pimecrolimus for the Treatment of Atopic Dermatitis in Infants: An Asian Perspective.
Chu CY; Yao TC; Shih IH; Yang CY; Chin CL; Ibrahim SBBK; Thevarajah S; Fon LK; Ho MH; Mo CC; Yu CP; Loo SK; Luger T
Dermatol Ther (Heidelb); 2023 Mar; 13(3):717-727. PubMed ID: 36735214
[TBL] [Abstract][Full Text] [Related]
10. A Comparison of Topical Corticosteroids and Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis.
Pena J; Zameza PA; Pixley JN; Remitz A; Feldman SR
J Allergy Clin Immunol Pract; 2023 May; 11(5):1347-1359. PubMed ID: 36997119
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
Breuer K; Werfel T; Kapp A
Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
[TBL] [Abstract][Full Text] [Related]
12. Unmet medical needs in the treatment of atopic dermatitis in infants: An Expert consensus on safety and efficacy of pimecrolimus.
Luger T; Augustin M; Lambert J; Paul C; Pincelli C; Torrelo A; Vestergaard C; Wahn U; Werfel T
Pediatr Allergy Immunol; 2021 Apr; 32(3):414-424. PubMed ID: 33251600
[TBL] [Abstract][Full Text] [Related]
13. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
Hebert AA
Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
[TBL] [Abstract][Full Text] [Related]
14. Topical tacrolimus in adult atopic dermatitis: a consensus based on a 15-year experience.
Calzavara-Pinton P; Fabbrocini G; Girolomoni G; Matiucci A; Micali G; Musumeci ML; Patruno C; Pellacani G; Rossi MT; Castello M; Stingeni L
G Ital Dermatol Venereol; 2020 Feb; 155(1):8-13. PubMed ID: 31760730
[TBL] [Abstract][Full Text] [Related]
15. Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis.
El-Batawy MM; Bosseila MA; Mashaly HM; Hafez VS
J Dermatol Sci; 2009 May; 54(2):76-87. PubMed ID: 19303745
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation.
Garside R; Stein K; Castelnuovo E; Pitt M; Ashcroft D; Dimmock P; Payne L
Health Technol Assess; 2005 Jul; 9(29):iii, xi-xiii,1-230. PubMed ID: 16022804
[TBL] [Abstract][Full Text] [Related]
17. Atopic dermatitis: a review of topical treatment options.
Simpson EL
Curr Med Res Opin; 2010 Mar; 26(3):633-40. PubMed ID: 20070141
[TBL] [Abstract][Full Text] [Related]
18. Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis.
Frankel A; Sohn A; Patel RV; Lebwohl M
J Drugs Dermatol; 2011 Jun; 10(6):666-72. PubMed ID: 21637908
[TBL] [Abstract][Full Text] [Related]
19. Spotlight on topical pimecrolimus in atopic dermatitis.
Wellington K; Jarvis B
Am J Clin Dermatol; 2002; 3(6):435-8. PubMed ID: 12113651
[TBL] [Abstract][Full Text] [Related]
20. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.
Wellington K; Jarvis B
Drugs; 2002; 62(5):817-40. PubMed ID: 11929333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]